GLP-1 consumer apps can help patients stay on track but have no evidence base; clinical-grade apps can do more but are not ...

SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, a leading virtual-first healthcare provider, announced an expansion of its GLP-1 companion solution, adding customized partner support for medication ...

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first time in a long time, ...

GLP-1 medications are now the go-to weight loss solution for millions of Americans. With 1 in 8 Americans having tried them, demand is clear and so are the challenges. Side effects like ...

The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron (marketed as Foundayo) for adults with obesity or those who are overweight and have ...

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse events tied to blockbuster diabetes and weight-loss medications during an open ...

Early data from first participating employer show that Smart Rx can save organizations millions by bypassing traditional PBMs to deliver brand-name GLP-1 medications NEW YORK, April 23, 2026 (GLOBE ...

There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.

Samsung has teamed up with diabetes experts at Massachusetts General Hospital to see how Galaxy Watch 8 can help prevent muscle loss in GLP-1 patients.